Acquiring Company
Galmed Pharmaceuticals Ltd
Acquired Company
Colospan Ltd
Tel Aviv District
RaipurBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
Galmed Pharmaceuticals has announced its acquisition of Colospan, aimed at creating a GI-focused platform. Colospan will become a wholly owned subsidiary, enhancing Galmed's capabilities with its innovative medical device technologies. The acquisition is expected to close in Q2 2026 and has been unanimously approved by both companies' boards.
Quick answer
Galmed Pharmaceuticals Ltd is acquiring Colospan Ltd, announced June 8, 2026. Galmed Pharmaceuticals Ltd is based in Tel Aviv District, Israel.
- How much did Galmed Pharmaceuticals Ltd pay for Colospan Ltd?
- The deal value was not disclosed.
- What does Galmed Pharmaceuticals Ltd do?
- Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing innovative therapies for liver diseases and other conditions.
- Where are Galmed Pharmaceuticals Ltd and Colospan Ltd based?
- Galmed Pharmaceuticals Ltd is based in Tel Aviv District, Israel. Colospan Ltd is based in Raipur, Chhattisgarh, India.
- Who are the decision-makers at Galmed Pharmaceuticals Ltd?
- Fundz holds 2 contacts at Galmed Pharmaceuticals Ltd. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Medtronic to acquire SPR Therapeutics for chronic pain care (May 20, 2026)
- Gilead Sciences to acquire MacroGenics for $1.7B, $1.7B (May 19, 2026)
- ESTEVE acquires TerSera's Infusion Business Unit (May 4, 2026)
- Eli Lilly to acquire Ajax Therapeutics for $2.3B, $2.3B (April 27, 2026)
- Vertex to acquire Crinetics Pharmaceuticals for $10B, $10B (July 6, 2026)
Who to call at Galmed Pharmaceuticals Ltd, and when
When Galmed Pharmaceuticals Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Galmed Pharmaceuticals Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Galmed Pharmaceuticals Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Galmed Pharmaceuticals Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Galmed Pharmaceuticals Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Colospan Ltd?
Colospan Ltd was acquired by Galmed Pharmaceuticals Ltd, based in Tel Aviv District. The deal was reported on June 8, 2026. Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing innovative therapies for liver diseases and other conditions. Galmed Pharmaceuticals Ltd is publicly traded (EOCN) and operates in Biotechnology.
When did Galmed Pharmaceuticals Ltd acquire Colospan Ltd?
Galmed Pharmaceuticals Ltd's acquisition of Colospan Ltd was reported on June 8, 2026. Galmed Pharmaceuticals has announced its acquisition of Colospan, aimed at creating a GI-focused platform. Colospan will become a wholly owned subsidiary, enhancing Galmed's capabilities with its innovative medical device technologies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Colospan Ltd do?
Colospan Ltd. is a commercial-stage medical device company specializing in innovative solutions for colorectal surgery complications, particularly addressing anastomotic leaks. It is privately held, operating in Manufacturing, and is based in Raipur.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.